CYPHERPUNK TECHNOLOGIES INC. Interest Expense Nonoperating
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Interest Expense Nonoperating of $6.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-12
- CYPHERPUNK TECHNOLOGIES INC. interest expense nonoperating for the quarter ending 2026-06-30 was $6.00K, a 14.29% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. interest expense nonoperating for the quarter ending 2026-03-31 was $7.00K, a 16.67% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. interest expense nonoperating for the quarter ending 2025-12-31 was $1.00K.
- CYPHERPUNK TECHNOLOGIES INC. interest expense nonoperating for the quarter ending 2025-09-30 was $10.00K.
- CYPHERPUNK TECHNOLOGIES INC. interest expense nonoperating for fiscal 2025 was $24.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.00K 10-Q · filed 2026-08-12 | $13.00K 10-Q · filed 2026-08-12 | $14.00K derived: sum of 3 quarters · filed 2026-08-12 | $24.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $7.00K 10-Q · filed 2026-05-14 | $8.00K derived: sum of 2 quarters · filed 2026-05-14 | $18.00K derived: sum of 3 quarters · filed 2026-05-14 | $25.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $11.00K derived: sum of 2 quarters · filed 2026-03-16 | $18.00K derived: sum of 3 quarters · filed 2026-08-12 | $24.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | $10.00K 10-Q · filed 2025-11-12 | $17.00K derived: sum of 2 quarters · filed 2026-08-12 | $23.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $7.00K 10-Q · filed 2026-08-12 | $13.00K 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | $6.00K 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |